2nd Quarter - Report
MEHLMAN CONSULTING, INC. for BIOGEN IDEC INC.
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform implementation issues; follow on biologics. Prescription drug user fee reauthorization and FDA reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Taxation/Internal Revenue Code TAX
International tax issues, including repatriation, deferral, check the box, pharmaceutical tax and transfer pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Medicare/Medicaid MMM
Health reform implementation issues. Independent Payment Advisory Board. Medicare Part D Rebate.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.